Literature DB >> 30008061

The Effect of the Bariatric Surgery Type on the Levothyroxine Dose of Morbidly Obese Hypothyroid Patients.

Jorge Pedro1, Filipe Cunha2, Pedro Souteiro3, João Sérgio Neves3, Vanessa Guerreiro3, Daniela Magalhães3, Rita Bettencourt-Silva3, Sofia Castro Oliveira3, Maria Manuel Costa3, Joana Queirós3, Paula Freitas3, Ana Varela3, Davide Carvalho3.   

Abstract

BACKGROUND: Doubts exist about the effect of different bariatric surgery (BS) types on levothyroxine (Lt4) absorption. We compared Lt4 doses and their variation (ΔLt4) in patients with hypothyroidism that underwent malabsorptive (MS) or restrictive (RS) surgery and studied predictors of Lt4 dose change.
METHODS: Retrospective study of morbidly obese hypothyroid patients submitted to BS. We compared RS ("sleeve" gastrectomy or adjustable gastric banding) with MS (Roux-en-Y gastric bypass) patients. We built a multivariable logistic regression and a linear regression model to study predictors of Lt4 dose changes and ΔLt4, respectively.
RESULTS: Fifty-seven patients: 35 MS and 22 RS. Mean age 47 years; 7% men. Patients submitted to MS had lower BMI at 1 year than those submitted to RS. Lt4 dose remained unchanged in 61.4%, increased in 12.3%, and decreased in 26.3% of patients. Initial and 1-year Lt4 dose were not different between surgical groups. Relative Lt4 dose, but not absolute (p = 0.07), increased at 1 year (p < 0.001). Neither BS nor BMI variation were predictors of Lt4 dose variation. BMI variation was associated with relative Lt4 dose change independently of initial BMI and BS type: β (95%CI) - 0.03 (- 0.05; 0.00); p = 0.03.
CONCLUSIONS: There were no differences in Lt4 dose and its variation between restrictive and malabsorptive techniques 1 year after surgery. Malabsorptive procedures may not affect Lt4 absorption differently from restrictive ones. Bariatric surgery type was not predictive of Lt4 dose changes. BMI variation is associated with relative Lt4 dose (dose per weight) variation and its association was independent of bariatric surgery type.

Entities:  

Keywords:  Bariatric surgery; Hypothyroidism; Levothyroxine; Malabsorptive procedures; Obesity; Restrictive procedures

Mesh:

Substances:

Year:  2018        PMID: 30008061     DOI: 10.1007/s11695-018-3388-4

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  31 in total

1.  Laparoscopic sleeve gastrectomy leads to reduction in thyroxine requirement in morbidly obese patients with hypothyroidism.

Authors:  Sandeep Aggarwal; Shrey Modi; Toney Jose
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

Review 2.  Vitamin, mineral, and drug absorption following bariatric surgery.

Authors:  Ronald Andari Sawaya; Jane Jaffe; Lindsay Friedenberg; Frank K Friedenberg
Journal:  Curr Drug Metab       Date:  2012-11       Impact factor: 3.731

3.  Malabsorption of thyroid hormones after jejunoileal bypass for obesity.

Authors:  F Azizi; R Belur; J Albano
Journal:  Ann Intern Med       Date:  1979-06       Impact factor: 25.391

4.  Impaired pharmacokinetics of levothyroxine in severely obese volunteers.

Authors:  Marina A Michalaki; Margarita I Gkotsina; Irene Mamali; Georgios K Markantes; Amalia Faltaka; Fotios Kalfarentzos; Apostolos G Vagenakis; Kostas B Markou
Journal:  Thyroid       Date:  2011-03-21       Impact factor: 6.568

5.  Metabolic or bariatric surgery? Long-term effects of malabsorptive vs restrictive bariatric techniques on body composition and cardiometabolic risk factors.

Authors:  C Lubrano; S Mariani; M Badiali; M Cuzzolaro; G Barbaro; S Migliaccio; G Genovesi; F Rossi; M Celanetti; D Fiore; M M Pandolfo; P Specchia; G Spera
Journal:  Int J Obes (Lond)       Date:  2010-04-20       Impact factor: 5.095

Review 6.  Mechanisms responsible for excess weight loss after bariatric surgery.

Authors:  Viorica Ionut; Richard N Bergman
Journal:  J Diabetes Sci Technol       Date:  2011-09-01

7.  Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery.

Authors:  Jeffrey I Mechanick; Adrienne Youdim; Daniel B Jones; W Timothy Garvey; Daniel L Hurley; M Molly McMahon; Leslie J Heinberg; Robert Kushner; Ted D Adams; Scott Shikora; John B Dixon; Stacy Brethauer
Journal:  Obesity (Silver Spring)       Date:  2013-03       Impact factor: 5.002

Review 8.  Bariatric surgery to treat obesity.

Authors:  Hermann J Kissler; Utz Settmacher
Journal:  Semin Nephrol       Date:  2013-01       Impact factor: 5.299

9.  Improved levothyroxine pharmacokinetics after bariatric surgery.

Authors:  Margarita Gkotsina; Marina Michalaki; Irene Mamali; Georgios Markantes; George C Sakellaropoulos; Fotios Kalfarentzos; Apostolos G Vagenakis; Kostas B Markou
Journal:  Thyroid       Date:  2013-03-18       Impact factor: 6.568

10.  Thyroxine malabsorption following intestinal bypass surgery.

Authors:  J S Bevan; J F Munro
Journal:  Int J Obes       Date:  1986
View more
  7 in total

1.  Changes in Thyroid Replacement Therapy after Bariatric Surgery: Differences between Laparoscopic Roux-en-Y Gastric Bypass and Laparoscopic Sleeve Gastrectomy.

Authors:  Helena Julià; David Benaiges; Paula Mollà; Juan Pedro-Botet; Montserrat Villatoro; Laia Fontané; Jose M Ramon; Elisenda Climent; Juana A Flores Le Roux; Alberto Goday
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

2.  Major imbalance of thyroid function after laparoscopic sleeve gastrectomy.

Authors:  Laurent Brutus; Armelle Poupard; Clément Le Glatin
Journal:  BMJ Case Rep       Date:  2019-08-10

3.  Laparoscopic Sleeve Gastrectomy has A Positive Impact on Subclinical Hypothyroidism Among Obese Patients: A Prospective Study.

Authors:  Mohamed AbdAlla Salman; Ahmed Rabiee; Ahmed Salman; Mohamed G Qassem; Mahmoud A Ameen; Ahmed M Hassan; Ahmed Soliman; Hossam Shaaban; Ghada M K GabAllah; Ahmed A Ismail; Haitham S E Omar
Journal:  World J Surg       Date:  2021-06-26       Impact factor: 3.352

4.  Treatment with Intramuscular Levothyroxine in Refractory Hypothyroidism.

Authors:  María de Los Ángeles Garayalde Gamboa; Melina Saban; Marina Ines Curriá
Journal:  Eur Thyroid J       Date:  2019-10-22

Review 5.  Levothyroxine Therapy in Gastric Malabsorptive Disorders.

Authors:  Camilla Virili; Nunzia Brusca; Silvia Capriello; Marco Centanni
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-28       Impact factor: 5.555

Review 6.  Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults.

Authors:  Philippe Caron; Solange Grunenwald; Luca Persani; Françoise Borson-Chazot; Remy Leroy; Leonidas Duntas
Journal:  Rev Endocr Metab Disord       Date:  2021-10-20       Impact factor: 9.306

Review 7.  Thyroid Function Alteration in Obesity and the Effect of Bariatric Surgery.

Authors:  María Cordido; Paula Juiz-Valiña; Paula Urones; Susana Sangiao-Alvarellos; Fernando Cordido
Journal:  J Clin Med       Date:  2022-02-28       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.